Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years
- PMID: 30266249
- DOI: 10.1016/j.clgc.2018.08.004
Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years
Abstract
Background: The role of positive surgical margins (PSMs) on the recurrence of renal cell carcinoma (RCC) after partial nephrectomy (PN) is debated, and available evidence lacks long-term data. The aim of this study was to evaluate the predictive role of PSMs on progression-free survival (PFS) in a large cohort followed for at least 5 years.
Methods: This study was a retrospective analysis of a prospectively compiled single-institution database collecting complete information on more than 2700 patients who had undergone surgery for renal tumor. The data of all the patients submitted to PN for RCC and with least 5 years follow-up were extracted. Surgical specimens were examined at the time of surgery only by 2 expert uro-pathologists. A PSM was defined as the presence of cancer cells at the inked surface of the specimen. The role of PSMs on survival was estimated by Cox regression models adjusted for influent covariates.
Results: A total of 459 patients fulfilled the inclusion criteria and were evaluated. PSMs were observed in 27 (5.9%) cases. No differences in preoperative and pathologic data were found comparing patients with and without PSMs. At a median follow-up of 96 months (interquartile range, 74-131 months), a clinically evident relapse of RCC was diagnosed in 36 (7.8%) patients at a median interval of 36 months from PN. Among these, 6 had a PSM for an incidence of relapse of 22.2% in the PSM group, whereas 30 had negative margins, for an incidence of 6.9% (P = .013). The sites of relapse were distant organs in 18 cases, and the kidney underwent PN in 21. The patients with PSMs showed a borderline significantly higher incidence of distant metastasis (11.1% vs. 3.5%; P = .071) and a significantly higher incidence of renal relapses (14.8% vs. 3.9%; P = .029). Multivariable Cox models confirmed that the presence of PSMs was an independent predictor of PFS (odds ratio, 3.127; P = .013).
Conclusions: PSMs are an independent predictor of PFS in patients who underwent PN for RCC, owing to a higher incidence of distant and local relapses. Surveillance in presence of PSMs should be intensified and extended for a long time.
Keywords: Partial nephrectomy; Predictors; Prognosis; Recurrence; Renal Cell Carcinoma.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
The effect of surgical margin on cancer-specific survival in patients treated with nephron-sparing surgery.Niger J Clin Pract. 2019 Oct;22(10):1396-1402. doi: 10.4103/njcp.njcp_267_18. Niger J Clin Pract. 2019. PMID: 31607729
-
Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.World J Urol. 2018 Jul;36(7):1093-1101. doi: 10.1007/s00345-018-2241-7. Epub 2018 Feb 27. World J Urol. 2018. PMID: 29488096
-
Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.World J Surg Oncol. 2017 Nov 2;15(1):193. doi: 10.1186/s12957-017-1257-6. World J Surg Oncol. 2017. PMID: 29096642 Free PMC article.
-
Positive surgical margins after nephron-sparing surgery.Eur Urol. 2012 Apr;61(4):757-63. doi: 10.1016/j.eururo.2011.11.028. Epub 2011 Nov 24. Eur Urol. 2012. PMID: 22136987 Review.
-
Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management.Clin Genitourin Cancer. 2013 Mar;11(1):5-9. doi: 10.1016/j.clgc.2012.09.010. Epub 2012 Oct 17. Clin Genitourin Cancer. 2013. PMID: 23083800 Review.
Cited by
-
Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis.Front Oncol. 2021 Jun 3;11:678459. doi: 10.3389/fonc.2021.678459. eCollection 2021. Front Oncol. 2021. PMID: 34150642 Free PMC article.
-
The Impact of Metastasectomy on Survival Outcomes of Renal Cell Carcinoma: A 10-Year Single Center Experience.Cancers (Basel). 2023 Jun 25;15(13):3332. doi: 10.3390/cancers15133332. Cancers (Basel). 2023. PMID: 37444442 Free PMC article.
-
Solitary, Late Metastatic Recurrence of Renal Cell Carcinoma to the Pancreas: A Case Report.Cureus. 2020 Jun 9;12(6):e8521. doi: 10.7759/cureus.8521. Cureus. 2020. PMID: 32537281 Free PMC article.
-
Late recurrence of chromophobe renal cell carcinoma to unusual sites after 12 years of radical nephrectomy and radiotherapy: a rare case report from Syria.Ann Med Surg (Lond). 2023 Mar 25;85(4):1082-1087. doi: 10.1097/MS9.0000000000000333. eCollection 2023 Apr. Ann Med Surg (Lond). 2023. PMID: 37113924 Free PMC article.
-
Laparoscopic Versus Open Partial Nephrectomy: A Systemic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes.Front Oncol. 2020 Oct 29;10:583979. doi: 10.3389/fonc.2020.583979. eCollection 2020. Front Oncol. 2020. PMID: 33194725 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous